Adithya Balasubramanian

3PUBLICATIONS
43CO-AUTHORS
Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 10, 2026
A Phase 1 and Biodistribution study of Ifabotuzumab, a humanized agonistic EphA3-targeted antibody, in patients with recurrent glioblastoma.

|Mar 18, 2026
Recent Advances in Combined Medical and Surgical Therapy for Resectable NSCLC.

Adithya Balasubramanian, James Geng, Catherine Williams

|Sep 11, 2025
Effects of CVA21, an Oncolytic Virus, in Combination with Pembrolizumab on Immunogenicity and the Tumor Microenvironment in Advanced NSCLC: A Phase I/II Trial.

Adithya Balasubramanian, Claire Marceaux, Sehrish Kanwal

Pageof 1